Combining combined with chemotherapy anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Cell Line, Tumor Tumor Cells, Cultured HCT116 Cells HT29 Cells MCF-7 Cells Cell Line

Organisms3

Mice, Nude Mice, Inbred BALB C Mice, SCID

Diseases50

Radiation Injuries Neoplasms Breast Neoplasms Lung Neoplasms Radiation Pneumonitis Radiation Injuries, Experimental Neoplasm Recurrence, Local Adenocarcinoma Neoplasms, Radiation-Induced Brain Neoplasms Carcinoma, Non-Small-Cell Lung Ovarian Neoplasms Neoplasm Metastasis Colonic Neoplasms Carcinoma, Squamous Cell Colorectal Neoplasms Liver Neoplasms Head and Neck Neoplasms Hodgkin Disease Lymphoma, Non-Hodgkin Osteosarcoma Carcinoma Bone Neoplasms Testicular Neoplasms Vomiting Neutropenia Nausea Neoplasms, Experimental Stomach Neoplasms Lymphoma Acute Radiation Syndrome Pancreatic Neoplasms Glioma Glioblastoma Neoplasms, Germ Cell and Embryonal Leukopenia Lymphatic Metastasis Disease Progression Recurrence Precursor Cell Lymphoblastic Leukemia-Lymphoma Sarcoma Melanoma Leukemia, Radiation-Induced Peritoneal Neoplasms Radiodermatitis Leukemia Germinoma Leukemia P388 Neoplasms, Second Primary Stomatitis

Chemicals and Drugs87

Antineoplastic Agents Doxorubicin Cisplatin Etoposide Cyclophosphamide Antineoplastic Agents, Phytogenic Paclitaxel Antibiotics, Antineoplastic Vinblastine Camptothecin Methotrexate Antimetabolites, Antineoplastic Organoplatinum Compounds Carboplatin Bleomycin Taxoids Antineoplastic Agents, Alkylating Drug Carriers Deoxycytidine Radiation-Sensitizing Agents P-Glycoprotein Daunorubicin Anthracyclines Mitomycin Mitoxantrone Ellipticines Platinum Ifosfamide Cytarabine Dacarbazine Platinum Compounds Tumor Suppressor Protein p53 Radiation-Protective Agents Prodrugs DNA Topoisomerases, Type II Carmustine Enzyme Inhibitors Tumor Markers, Biological Melphalan Topoisomerase I Inhibitors Proto-Oncogene Proteins c-bcl-2 Neoplasm Proteins Antibodies, Monoclonal Nimustine Tegafur Antibodies, Monoclonal, Humanized Plant Extracts Angiogenesis Inhibitors Caspases Fluorouracil Lomustine Adjuvants, Pharmaceutic Chlorambucil Multidrug Resistance-Associated Proteins Nanocapsules Floxuridine Caspase 3 DNA Teniposide Cobalt Radioisotopes Topotecan Razoxane Drugs, Investigational Granulocyte Colony-Stimulating Factor Antiemetics Thiotepa Topoisomerase II Inhibitors DNA-Binding Proteins Mitomycins RNA, Small Interfering ATP-Binding Cassette Transporters Protein Kinase Inhibitors DNA Adducts RNA, Messenger Topoisomerase Inhibitors Quinazolines DNA, Neoplasm Intercalating Agents Bridged Compounds Liposomes Radiopharmaceuticals Tubulin Modulators Receptor, erbB-2 Pyrazines Xanthones DNA Topoisomerases, Type I Recombinant Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment70

Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Radiation Dosage Combined Modality Therapy Dose-Response Relationship, Radiation Drug Screening Assays, Antitumor Treatment Outcome Radiation Monitoring Disease-Free Survival Radiotherapy Neoadjuvant Therapy Neoplasm Staging Survival Analysis Drug Delivery Systems Prognosis Drug Administration Schedule Survival Rate Xenograft Model Antitumor Assays Radiotherapy Dosage Drug Carriers Radiation Injuries, Experimental Radiotherapy, Adjuvant Induction Chemotherapy Clinical Trials as Topic Inhibitory Concentration 50 Follow-Up Studies Radiometry Drug Design Salvage Therapy Neoplasm Transplantation Dose Fractionation Radiotherapy, Conformal Chemotherapy, Cancer, Regional Perfusion Drug Evaluation, Preclinical Molecular Targeted Therapy Hyperthermia, Induced Prospective Studies Tumor Burden Neoplasms, Experimental Transplantation, Autologous Chemoradiotherapy Kaplan-Meier Estimate Cranial Irradiation Flow Cytometry Radiotherapy, Intensity-Modulated Tomography, X-Ray Computed Nanocapsules Transplantation, Heterologous Drug Discovery Blotting, Western Brachytherapy Palliative Care Models, Biological Infusions, Intra-Arterial Infusions, Intravenous Drug Therapy Clinical Trials, Phase I as Topic Immunohistochemistry Radiation Hybrid Mapping Administration, Oral Hematopoietic Stem Cell Transplantation Randomized Controlled Trials as Topic Actuarial Analysis Whole-Body Irradiation Feasibility Studies Drug Evaluation Tumor Stem Cell Assay Radiotherapy, High-Energy Positron-Emission Tomography Radiotherapy Planning, Computer-Assisted

Phenomena and Processes35

Radiation Dosage Radiation, Ionizing Dose-Response Relationship, Radiation Radiation Tolerance Radiation Drug Resistance, Neoplasm Apoptosis Cell Survival Dose-Response Relationship, Drug Time Factors Gamma Rays Cosmic Radiation DNA Damage Cell Proliferation Drug Resistance, Multiple Drug Synergism Background Radiation Inhibitory Concentration 50 Ultraviolet Rays Gene Expression Regulation, Neoplastic Cell Cycle Molecular Structure Radiation Effects DNA Repair Signal Transduction Drug Resistance Cell Division Cell Death X-Rays Genes, MDR DNA Adducts Mutation Structure-Activity Relationship Cell Cycle Checkpoints Down-Regulation

Disciplines and Occupations8

Radiation Oncology Drug Design Nanomedicine Drug Discovery Medical Oncology Immunohistochemistry Radiobiology Pharmacogenetics

Technology, Industry, Agriculture4

Nanoparticles Nanomedicine Nanocapsules Liposomes

Information Science4

Survival Rate Radiotherapy, Conformal Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted

Health Care24

Radiation Dosage Radiation Injuries Dose-Response Relationship, Radiation Radiation Protection Treatment Outcome Radiation Monitoring Disease-Free Survival Survival Analysis Survival Rate Cosmic Radiation Radiation Injuries, Experimental Clinical Trials as Topic Ultraviolet Rays Follow-Up Studies Radiation Effects Prospective Studies Kaplan-Meier Estimate Acute Radiation Syndrome Palliative Care Clinical Trials, Phase I as Topic Radioactive Hazard Release Randomized Controlled Trials as Topic Actuarial Analysis Feasibility Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents Chemotherapy, Adjuvant Radiation Dosage Radiation, Ionizing Radiation Injuries Doxorubicin Cisplatin Combined Modality Therapy Dose-Response Relationship, Radiation Neoplasms Radiation Tolerance Cell Line, Tumor Drug Screening Assays, Antitumor Radiation Drug Resistance, Neoplasm Radiation Protection Treatment Outcome Etoposide Radiation Monitoring Cyclophosphamide Breast Neoplasms Antineoplastic Agents, Phytogenic Apoptosis Paclitaxel Antibiotics, Antineoplastic Cell Survival Disease-Free Survival Radiotherapy Neoadjuvant Therapy Lung Neoplasms Neoplasm Staging Survival Analysis Radiation Oncology Vinblastine Camptothecin Drug Delivery Systems Prognosis Methotrexate Antimetabolites, Antineoplastic Drug Administration Schedule Organoplatinum Compounds Survival Rate Tumor Cells, Cultured Carboplatin Xenograft Model Antitumor Assays Radiotherapy Dosage Bleomycin Mice, Nude Dose-Response Relationship, Drug Taxoids Antineoplastic Agents, Alkylating Time Factors Gamma Rays Drug Carriers Radiation Pneumonitis Cosmic Radiation Radiation Injuries, Experimental DNA Damage Neoplasm Recurrence, Local Deoxycytidine Radiation-Sensitizing Agents Cell Proliferation Adenocarcinoma P-Glycoprotein Drug Resistance, Multiple Neoplasms, Radiation-Induced Daunorubicin Anthracyclines Radiotherapy, Adjuvant Brain Neoplasms Carcinoma, Non-Small-Cell Lung Mitomycin Ovarian Neoplasms Mitoxantrone Drug Synergism Induction Chemotherapy Clinical Trials as Topic Ellipticines Platinum Background Radiation Neoplasm Metastasis Ifosfamide Inhibitory Concentration 50 Cytarabine Ultraviolet Rays Follow-Up Studies Dacarbazine Gene Expression Regulation, Neoplastic Colonic Neoplasms Radiometry Cell Cycle Carcinoma, Squamous Cell Platinum Compounds Molecular Structure Drug Design Tumor Suppressor Protein p53 Colorectal Neoplasms Radiation-Protective Agents Liver Neoplasms

No FAQ available that match "combining combined with chemotherapy anticancer drugs or radiation"